In an in vivo investigation in severe asthma, Duechs et al. [59] discovered that TLR9 activation significantly reduced some features of the asthmatic phenotype such as a reduction in eosinophil influx and IgE levels in serum. This evidence concerns the gene TLR9 and asthma.